These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32239782)

  • 1. Pathology, diagnostics, and classification of medulloblastoma.
    Orr BA
    Brain Pathol; 2020 May; 30(3):664-678. PubMed ID: 32239782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Classification of Medulloblastoma.
    Kijima N; Kanemura Y
    Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
    Pietsch T; Haberler C
    Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
    Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
    Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales.
    Woolman M; Kuzan-Fischer CM; Ferry I; Kiyota T; Luu B; Wu M; Munoz DG; Das S; Aman A; Taylor MD; Rutka JT; Ginsberg HJ; Zarrine-Afsar A
    Cancer Res; 2019 May; 79(9):2426-2434. PubMed ID: 30890619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].
    Wataya T; Hamasaki M; Taylor MD
    No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
    Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
    Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized diagnosis of medulloblastoma subtypes across patients and model systems.
    Gendoo DM; Smirnov P; Lupien M; Haibe-Kains B
    Genomics; 2015 Aug; 106(2):96-106. PubMed ID: 25979459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E
    J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classifying the medulloblastoma: insights from morphology and molecular genetics.
    Ellison D
    Neuropathol Appl Neurobiol; 2002 Aug; 28(4):257-82. PubMed ID: 12175339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
    Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma genomics in the modern molecular era.
    Kumar R; Liu APY; Northcott PA
    Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging spectrum of medulloblastoma.
    Fruehwald-Pallamar J; Puchner SB; Rossi A; Garre ML; Cama A; Koelblinger C; Osborn AG; Thurnher MM
    Neuroradiology; 2011 Jun; 53(6):387-96. PubMed ID: 21279509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
    Ellison DW
    Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
    Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
    Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].
    Pietsch T
    Pathologe; 2019 Mar; 40(2):140-147. PubMed ID: 30790012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.